Physician profile
Michael E Abrams
NPI 1124273263
$2,256.98
in general payments reported to CMS, 2019-2025
13 companies · $81.89 in 2025
The $81.89 reported for 2025 was less than what a typical Periodontics provider received nationally (typical 2025 total: $111).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $471 · 2020: $73.88 · 2021: $263 · 2022: $162 · 2023: $1,053 · 2024: $153 · 2025: $81.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $788 · Travel and Lodging: $496 · Gift: $4.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $788.06 |
| Travel and Lodging | $495.51 |
| Gift | $4.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $888.67 | 2019-2023 | Invisalign |
| 3m Company | $303.69 | 2021-2022 | |
| Straumann USA LLC | $291.94 | 2023-2025 | |
| Biohorizons Implant Systems INC. | $222.70 | 2019-2020 | |
| Geistlich Pharma, North America, INC. | $181.26 | 2019 | |
| Keystone Dental INC. | $121.61 | 2019-2024 | |
| Nobel Biocare USA | $77.01 | 2021-2023 | Nobelactive |
| Dentsply Sirona INC | $49.75 | 2021-2023 | Midwest |
| Orapharma, A Division of Bausch Health US, LLC | $33.44 | 2019-2020 | |
| Solventum Corporation | $28.15 | 2024 | 3m, Clarity Aligners |
| Zimmer Biomet Holdings, INC. | $26.36 | 2020 | |
| Henry Schein, INC. | $17.28 | 2019 | |
| Mis Implants Technologies, INC. | $15.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Abrams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.